Id |
Subject |
Object |
Predicate |
Lexical cue |
T1 |
0-102 |
Sentence |
denotes |
SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis. |
T2 |
103-183 |
Sentence |
denotes |
Fibrosis and organ failure is a common endpoint for many chronic liver diseases. |
T3 |
184-307 |
Sentence |
denotes |
Much is known about the upstream inflammatory mechanisms provoking fibrosis and downstream potential for tissue remodeling. |
T4 |
308-437 |
Sentence |
denotes |
However, less is known about the transcriptional regulation in vivo governing fibrotic matrix deposition by liver myofibroblasts. |
T5 |
438-601 |
Sentence |
denotes |
This gap in understanding has hampered molecular predictions of disease severity and clinical progression and restricted targets for antifibrotic drug development. |
T6 |
602-797 |
Sentence |
denotes |
In this study, we show the prevalence of SOX9 in biopsies from patients with chronic liver disease correlated with fibrosis severity and accurately predicted disease progression toward cirrhosis. |
T7 |
798-949 |
Sentence |
denotes |
Inactivation of Sox9 in mice protected against both parenchymal and biliary fibrosis, and improved liver function and ameliorated chronic inflammation. |
T8 |
950-1003 |
Sentence |
denotes |
SOX9 was downstream of mechanosignaling factor, YAP1. |
T9 |
1004-1221 |
Sentence |
denotes |
These data demonstrate a role for SOX9 in liver fibrosis and open the way for the transcription factor and its dependent pathways as new diagnostic, prognostic, and therapeutic targets in patients with liver fibrosis. |
T1 |
0-102 |
Sentence |
denotes |
SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis. |
T2 |
103-183 |
Sentence |
denotes |
Fibrosis and organ failure is a common endpoint for many chronic liver diseases. |
T3 |
184-307 |
Sentence |
denotes |
Much is known about the upstream inflammatory mechanisms provoking fibrosis and downstream potential for tissue remodeling. |
T4 |
308-437 |
Sentence |
denotes |
However, less is known about the transcriptional regulation in vivo governing fibrotic matrix deposition by liver myofibroblasts. |
T5 |
438-601 |
Sentence |
denotes |
This gap in understanding has hampered molecular predictions of disease severity and clinical progression and restricted targets for antifibrotic drug development. |
T6 |
602-797 |
Sentence |
denotes |
In this study, we show the prevalence of SOX9 in biopsies from patients with chronic liver disease correlated with fibrosis severity and accurately predicted disease progression toward cirrhosis. |
T7 |
798-949 |
Sentence |
denotes |
Inactivation of Sox9 in mice protected against both parenchymal and biliary fibrosis, and improved liver function and ameliorated chronic inflammation. |
T8 |
950-1003 |
Sentence |
denotes |
SOX9 was downstream of mechanosignaling factor, YAP1. |
T9 |
1004-1221 |
Sentence |
denotes |
These data demonstrate a role for SOX9 in liver fibrosis and open the way for the transcription factor and its dependent pathways as new diagnostic, prognostic, and therapeutic targets in patients with liver fibrosis. |